MedPath

Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation

Phase 4
Completed
Conditions
Neuropathic Pain Rebel
Registration Number
NCT00241566
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

All neuropathic chronicle pains are difficult to treat. Currently many patients are not relieved by electric stimulations of central nervous system, existing. Recently cortical stimulation had a development important and benefit effects are proven. In this study we evaluate medico-economic impact of this treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Presence of pain caused by lesion of central or peripheral nervous system
  • Pain persistent since one year at least
  • Pain untreated with 3 different antalgic treatments

Exclusion Criteria

  • Pain linked t a malignant affection
  • patient < 18 years-old
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Cost of treatment of this pathology
Secondary Outcome Measures
NameTimeMethod
Evaluation of the pain when the electric stimulation is off or on (during one month for each one). Using Visual Analogic Scale.

Trial Locations

Locations (2)

Clermont-Ferrand UH

🇫🇷

Clermont-Ferrand, Auvergne, France

Neurosurgery - Henri Mondor Hospital

🇫🇷

Créteil, Ile de France, France

© Copyright 2025. All Rights Reserved by MedPath